Patent · US Expired

Peptides for the treatment of cancer associated with the human papilloma virus (HPV) and other epithelial tumors

US7374767B2 · kind B2 · utility

2Cited by
0References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 4, 2002
Grant dateMay 20, 2008
Priority date
Expiry dateJul 11, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/20032
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention is related to the Molecular Pharmacology field and especially to the development of peptides useful for treating epithelial tumors and mainly those associated to oncogenic types of HPVs. The main objective of this invention is to identify peptides whose structure permits to block the Casein Kinase II (CKII) phosphorylation domain by direct interaction with such a site. In the present invention it is shown eleven cyclic peptides with different aminoacid sequences which inhibit the CKII phosphorylation in vitro, exhibit cytotoxicity on HPV-16 transformed cells (CaSki) and also increase the sensitivity of these cells to the cytostatic effect of interferon (IFN). Furthermore, the invention relates to the use of these peptides conjugated or fused to other peptides and chemical compounds which penetrates into cells as well as with the use of both peptide and chemical mimetic molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.